Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis
W Yan, D Chen, FM Bigambo, H Wei, X Wang… - BMC infectious …, 2021 - Springer
Background Due to the rapid spread of coronavirus disease 2019 (COVID-19) worldwide, it
is necessary to ascertain essential immune inflammatory parameters that describe the …
is necessary to ascertain essential immune inflammatory parameters that describe the …
The dynamics of immune response in COVID‐19 patients with different illness severity
B Zhang, D Yue, Y Wang, F Wang… - Journal of medical …, 2021 - Wiley Online Library
This study aimed to analyze the dynamic changes of lymphocyte subsets and specific
antibodies in coronavirus disease 2019 (COVID‐19) patients with different illness severity …
antibodies in coronavirus disease 2019 (COVID‐19) patients with different illness severity …
Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
XU Bo, C Fan, A Wang, Y Zou, Y Yu, HE Cong, W Xia… - Journal of Infection, 2020 - Elsevier
Importance An ongoing outbreak of COVID-19 has exhibited significant threats around the
world. We found a significant decrease of T lymphocyte subsets and an increase of …
world. We found a significant decrease of T lymphocyte subsets and an increase of …
[HTML][HTML] Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
CK Kang, GC Han, M Kim, G Kim, HM Shin… - International Journal of …, 2020 - Elsevier
Objectives We hypothesized that immune response may contribute to progression of
coronavirus disease-19 (COVID-19) at the second week of illness. Therefore, we compared …
coronavirus disease-19 (COVID-19) at the second week of illness. Therefore, we compared …
Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19
Y Ouyang, J Yin, W Wang, H Shi, Y Shi… - Clinical infectious …, 2020 - academic.oup.com
Abstract Background The World Health Organization characterizes novel coronavirus
disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome …
disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome …
Immune dysfunction following COVID-19, especially in severe patients
CY Song, J Xu, JQ He, YQ Lu - Scientific reports, 2020 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) has been spreading worldwide. Severe
cases quickly progressed with unfavorable outcomes. We aim to investigate the clinical …
cases quickly progressed with unfavorable outcomes. We aim to investigate the clinical …
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
R Chen, L Sang, M Jiang, Z Yang, N Jia, W Fu… - Journal of Allergy and …, 2020 - Elsevier
Background Crucial roles of hematologic and immunologic responses in progression of
coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to …
coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to …
Clinical and immunological features of severe and moderate coronavirus disease 2019
G Chen, DI Wu, W Guo, Y Cao… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Since December 2019, an outbreak of coronavirus disease 2019 (COVID-
19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in …
19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in …
Immunity profiling of COVID-19 infection, dynamic variations of lymphocyte subsets, a comparative analysis on four different groups
MG Balzanelli, P Distratis, G Dipalma, L Vimercati… - Microorganisms, 2021 - mdpi.com
Background: A novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) emerged
in December 2019 in China, spreading worldwide. The aim of the present investigation was …
in December 2019 in China, spreading worldwide. The aim of the present investigation was …
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients
P Zhang, W Du, T Yang, L Zhao… - International …, 2021 - journals.sagepub.com
Background Coronavirus disease 2019 (COVID-19) had become a worldwide health threat.
Early prediction of the severity of COVID-19 patients was important for reducing death rate …
Early prediction of the severity of COVID-19 patients was important for reducing death rate …